Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 9, 2005

Study Completion Date

June 25, 2007

Conditions

Paroxysmal Hemoglobinuria, Nocturnal

Interventions

DRUG

Eculizumab

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00130000 - Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria | Biotech Hunter | Biotech Hunter